Cargando…
Characterization of SHCBP1 to prognosis and immunological landscape in pan-cancer: novel insights to biomarker and therapeutic targets
Background: Previous studies have revealed the significant roles of SHC SH2 domain-binding protein 1 (SHCBP1) in occurrence and progression of cancers, but there is no pan-cancer analysis of SHCBP1. Methods: In this study, we explored the potential carcinogenic role of SHCBP1 across 33 tumors from t...
Autores principales: | Jiang, Fei, Shi, Yanlong, Wang, Yue, Ge, Chang, Zhu, Jun, Fang, Hanlu, Zhang, Yu, Zhang, Yixiao, Jian, Haokun, Lei, Tong, Lan, Sheng, Cao, Liyu, Yu, Hongzhu, Fang, Debao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10085602/ https://www.ncbi.nlm.nih.gov/pubmed/36920183 http://dx.doi.org/10.18632/aging.204591 |
Ejemplares similares
-
Upregulated UBE4B expression correlates with poor prognosis and tumor immune infiltration in hepatocellular carcinoma
por: Shao, Xuyang, et al.
Publicado: (2022) -
Deciphering a mitochondria-related signature to supervise prognosis and immunotherapy in hepatocellular carcinoma
por: Shi, Yanlong, et al.
Publicado: (2022) -
NCAPG facilitates colorectal cancer cell proliferation, migration, invasion and epithelial–mesenchymal transition by activating the Wnt/β-catenin signaling pathway
por: Shi, Yanlong, et al.
Publicado: (2022) -
Downregulation of SHCBP1 Inhibits Proliferation, Migration, and Invasion in Human Nasopharyngeal Carcinoma Cells
por: Zhang, Tian, et al.
Publicado: (2021) -
A novel epithelial–mesenchymal transition gene signature for the immune status and prognosis of hepatocellular carcinoma
por: Shi, Yanlong, et al.
Publicado: (2022)